1-1 of 1
Naja Nyffenegger
Close
Sort by
Journal Articles

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease

Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda, Anna Flace, Giada Ingoglia, Raphael M. Buzzi, Cédric Doucerain, Paul W. Buehler, Dominik J. Schaer, Franz Dürrenberger, Vania Manolova
Journal: Blood
Blood (2022) 140 (7): 769–781.
https://doi.org/10.1182/blood.2021014716
Published: 2022
Includes: Multimedia, Supplemental data